The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALKS US 01/18/19 C45 | Listed Option | G01767905 | 163 | 500 | SH | Call | SOLE | 500 | 0 | 0 | |
ALKS US 12/21/18 C45 | Listed Option | G01767905 | 533 | 1,500 | SH | Call | SOLE | 1,500 | 0 | 0 | |
AMGN US 01/18/19 P210 | Listed Option | 031162950 | 197 | 200 | SH | Put | SOLE | 200 | 0 | 0 | |
ATRICURE INC | Equity | 04963C209 | 9,633 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
BIO-RAD LABORATORIES-A | Equity | 090572207 | 20,344 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
CORIUM INTERNATIONAL INC | Equity | 21887L107 | 13,552 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | ||
CORREVIO PHARMA CORP | Equity | 22026V105 | 8,281 | 2,060,000 | SH | SOLE | 2,060,000 | 0 | 0 | ||
GILEAD SCIENCES INC | Equity | 375558103 | 13,512 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
GILD US 01/18/19 C85 | Listed Option | 375558903 | 340 | 2,500 | SH | Call | SOLE | 2,500 | 0 | 0 | |
GLAUKOS CORP | Equity | 377322102 | 4,868 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
HOLOGIC INC | Equity | 436440101 | 14,343 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
IWM US 10/19/18 P165 | Listed Option | 464287951 | 539 | 7,000 | SH | Put | SOLE | 7,000 | 0 | 0 | |
LABORATORY CRP OF AMER HLDGS | Equity | 50540R409 | 27,789 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
LANTHEUS HOLDINGS INC | Equity | 516544103 | 14,502 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
MDCO US 10/19/18 P20 | Listed Option | 584688955 | 25 | 1,000 | SH | Put | SOLE | 1,000 | 0 | 0 | |
MDCO US 10/19/18 P25 | Listed Option | 584688955 | 47 | 1,000 | SH | Put | SOLE | 1,000 | 0 | 0 | |
ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 26,442 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
MEDTRONIC PLC | Equity | 585055106 | 25,576 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
MODEL N INC | Equity | 607525102 | 1,585 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NUVASIVE INC | Equity | 670704105 | 37,412 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
NOVOCURE LTD | Equity | G6674U908 | 33,414 | 635,000 | SH | SOLE | 635,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | Equity | 67072V103 | 16,734 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
OBALON THERAPEUTICS INC | Equity | 67424L100 | 5,670 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
OPHTHOTECH CORP | Equity | 683745103 | 2,360 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
OPTINOSE INC | Equity | 68404V100 | 10,690 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | Equity | 695127100 | 7,373 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | Equity | 766559603 | 14,606 | 4,550,000 | SH | SOLE | 4,550,000 | 0 | 0 | ||
SERVICE CORP INTERNATIONAL | Equity | 817565104 | 9,452 | 213,856 | SH | SOLE | 213,856 | 0 | 0 | ||
SPY US 10/19/18 P290 | Listed Option | 78462F953 | 294 | 1,500 | SH | Put | SOLE | 1,500 | 0 | 0 | |
STERICYCLE INC | Equity | 858912108 | 21,712 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 2,242 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
VITAMIN SHOPPE INC | Equity | 92849E101 | 6,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 |